Recon: Lilly's weight loss pill shows disappointing results; FDA moves to boost US drug manufacturing

ReconReconBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States